ENOVIS CORP (ENOV) Stock Overview
NYSE:ENOV - US1940141062 - Common Stock
ENOV Key Statistics, Chart & Performance
The current stock price of ENOV is 31.02 USD. In the past month the price increased by 14.76%. In the past year, price decreased by -33.43%.
ENOV Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 26.83 | 228.80B | ||
| ISRG | INTUITIVE SURGICAL INC | 58.53 | 168.90B | ||
| BSX | BOSTON SCIENTIFIC CORP | 37.41 | 156.87B | ||
| SYK | STRYKER CORP | 30.6 | 150.31B | ||
| MDT | MEDTRONIC PLC | 16.65 | 117.94B | ||
| BDX | BECTON DICKINSON AND CO | 13.69 | 56.01B | ||
| IDXX | IDEXX LABORATORIES INC | 53.36 | 51.27B | ||
| EW | EDWARDS LIFESCIENCES CORP | 31.48 | 47.50B | ||
| RMD | RESMED INC | 29.52 | 41.28B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.94 | 33.90B | ||
| DXCM | DEXCOM INC | 44.93 | 29.95B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 16.48 | 26.66B |
Related stock screener links
About ENOV
Company Profile
Enovis Corp. operates as a medical technology growth company. The company is headquartered in Wilmington, Delaware and currently employs 7,367 full-time employees. The company went IPO on 2008-05-08. The company is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. The company operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. The company also operates a Enovis Growth eXcellence business system (EGX).
Company Info
ENOVIS CORP
2711 Centerville Road, Suite 400
Wilmington DELAWARE US
Employees: 7367
Phone: 13022529160
ENOVIS CORP / ENOV FAQ
What is the stock price of ENOVIS CORP today?
The current stock price of ENOV is 31.02 USD. The price decreased by -0.48% in the last trading session.
What is the ticker symbol for ENOVIS CORP stock?
The exchange symbol of ENOVIS CORP is ENOV and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is ENOV stock listed?
ENOV stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for ENOVIS CORP stock?
17 analysts have analysed ENOV and the average price target is 55.42 USD. This implies a price increase of 78.66% is expected in the next year compared to the current price of 31.02. Check the ENOVIS CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ENOVIS CORP worth?
ENOVIS CORP (ENOV) has a market capitalization of 1.77B USD. This makes ENOV a Small Cap stock.
How many employees does ENOVIS CORP have?
ENOVIS CORP (ENOV) currently has 7367 employees.
What are the support and resistance levels for ENOVIS CORP (ENOV) stock?
ENOVIS CORP (ENOV) has a support level at 31.01 and a resistance level at 31.44. Check the full technical report for a detailed analysis of ENOV support and resistance levels.
Is ENOVIS CORP (ENOV) expected to grow?
The Revenue of ENOVIS CORP (ENOV) is expected to grow by 7.28% in the next year. Check the estimates tab for more information on the ENOV EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ENOVIS CORP (ENOV) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ENOV, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ENOV, evaluating the profitability, health, valuation and growth aspects
- ENOVIS CORP (ENOV) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ENOVIS CORP (ENOV) Sales and EPS estimates to see what analysts future expectations are.
- ENOVIS CORP (ENOV) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ENOVIS CORP (ENOV) Insider and Institutional Ownership to learn about the owners and their transactions.
- ENOVIS CORP (ENOV) Stock Chart to make your own analysis
- ENOVIS CORP (ENOV) Latest news and press-releases to stay up to date.
Does ENOVIS CORP (ENOV) stock pay dividends?
ENOV does not pay a dividend.
When does ENOVIS CORP (ENOV) report earnings?
ENOVIS CORP (ENOV) will report earnings on 2025-11-04, before the market open.
What is the Price/Earnings (PE) ratio of ENOVIS CORP (ENOV)?
The PE ratio for ENOVIS CORP (ENOV) is 9.37. This is based on the reported non-GAAP earnings per share of 3.31 and the current share price of 31.02 USD. Check the full fundamental report for a full analysis of the valuation metrics for ENOV.
What is the Short Interest ratio of ENOVIS CORP (ENOV) stock?
The outstanding short interest for ENOVIS CORP (ENOV) is 12.23% of its float. Check the ownership tab for more information on the ENOV short interest.
ENOV Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to ENOV. When comparing the yearly performance of all stocks, ENOV is a bad performer in the overall market: 88.54% of all stocks are doing better.
ENOV Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to ENOV. ENOV may be in some trouble as it scores bad on both profitability and health.
ENOV Financial Highlights
Over the last trailing twelve months ENOV reported a non-GAAP Earnings per Share(EPS) of 3.31. The EPS increased by 34.01% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -16.48% | ||
| ROE | -32.1% | ||
| Debt/Equity | 0.53 |
ENOV Forecast & Estimates
17 analysts have analysed ENOV and the average price target is 55.42 USD. This implies a price increase of 78.66% is expected in the next year compared to the current price of 31.02.
For the next year, analysts expect an EPS growth of 12.61% and a revenue growth 7.28% for ENOV